Skip to search formSkip to main contentSkip to account menu

CV 2619

Known as: CV-2619 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
6-(10-Hydroxydecyl)-2, 3-dimethoxy-5-methyl-1, 4-benzoquinone (CV-2619) and related compounds (the corresponding hydroquinone and… 
Highly Cited
1985
Highly Cited
1985
Effect of idebenone (CV-2619) on memory impairment was studied in rats with cerebral embolization. The cerebral embolization… 
1985
1985
Metabolic studies of idebenone (CV-2619), a new cerebral metabolism improving agent, in the rat and dog by thin-layer… 
1985
1985
The addition of CV-2619 (10(-4) M) stimulated the release of endogenous 5-hydroxytryptamine (5-HT) markedly and that of… 
1985
1985
The effect of 6-(10-hydroxydecyl)-2, 3-dimethoxy-5-methyl-1, 4-benzoquinone (idebenone, CV-2619) on brightness discrimination… 
1984
1984
Improvement of energy metabolism in ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular lesions. In the… 
1982
1982
Effects of CV-2619 and ubiquinone-10 (Q-10) on the energy metabolism of red blood cells (RBC) of Sprague Dawley rats were studied… 
1982
1982
Antidote actions of CV-2619 and ubiquinone-10 (Q-10) against adriamycin (ADM) cardiotoxicity were studied in spontaneously…